Mankind Pharma Limited (MANKIND.BO)
INR 2343.55
(-1.47%)
INR 2343.55
(-1.47%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 19.12 Billion INR | 49.23% |
| 2022 | 12.81 Billion INR | -10.58% |
| 2021 | 14.33 Billion INR | 13.28% |
| 2020 | 12.65 Billion INR | 22.81% |
| 2019 | 10.3 Billion INR | 78.11% |
| 2018 | 5.78 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 5.36 Billion INR | 13.85% |
| 2023 Q1 | 4.86 Billion INR | 70.57% |
| 2023 Q3 | 4.53 Billion INR | -9.43% |
| 2023 FY | 19.12 Billion INR | 49.23% |
| 2023 Q4 | 4.71 Billion INR | 3.85% |
| 2023 Q2 | 5.01 Billion INR | 2.91% |
| 2022 Q4 | 2.85 Billion INR | 0.45% |
| 2022 Q2 | 4.19 Billion INR | 43.46% |
| 2022 Q3 | 2.84 Billion INR | -32.3% |
| 2022 FY | 12.81 Billion INR | -10.58% |
| 2022 Q1 | 2.92 Billion INR | 53.91% |
| 2021 Q4 | 1.9 Billion INR | 0.0% |
| 2021 FY | 14.33 Billion INR | 13.28% |
| 2020 FY | 12.65 Billion INR | 22.81% |
| 2019 FY | 10.3 Billion INR | 78.11% |
| 2018 FY | 5.78 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -210.626% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 39.713% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -306.232% |
| Granules India Limited | 4.05 Billion INR | -371.959% |
| Indoco Remedies Limited | 984.6 Million INR | -1842.814% |
| Achyut Healthcare Limited | 5.73 Million INR | -333622.383% |
| Ajanta Pharma Limited | 8.16 Billion INR | -134.375% |
| Alkem Laboratories Limited | 17.95 Billion INR | -6.522% |
| Alpa Laboratories Limited | 167.76 Million INR | -11302.239% |
| Brooks Laboratories Limited | -195.91 Million INR | 9863.712% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -1084.383% |
| Bajaj HealthCare Limited | -837.93 Million INR | 2382.881% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -2435.179% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 65.647% |
| Eris Lifesciences Limited | 3.91 Billion INR | -388.005% |
| FDC Limited | 3.05 Billion INR | -526.72% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 227.385% |
| Gufic Biosciences Limited | 861.35 Million INR | -2120.797% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -354.411% |
| Ipca Laboratories Limited | 5.47 Billion INR | -249.483% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -8415.767% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 9796.157% |
| Lasa Supergenerics Limited | -217.3 Million INR | 8902.779% |
| Laurus Labs Limited | 1.6 Billion INR | -1091.465% |
| Lupin Limited | 19.14 Billion INR | 0.083% |
| Medicamen Biotech Limited | 109.31 Million INR | -17399.741% |
| Medico Remedies Limited | 82.9 Million INR | -22972.244% |
| Megasoft Limited | -127.46 Million INR | 15107.113% |
| NATCO Pharma Limited | 13.88 Billion INR | -37.787% |
| Piramal Pharma Limited | 178.2 Million INR | -10634.549% |
| RPG Life Sciences Limited | 876.6 Million INR | -2082.177% |
| Sigachi Industries Limited | 571.8 Million INR | -3245.383% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 80.025% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -537.037% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -7456.615% |
| Unichem Laboratories Limited | -704.74 Million INR | 2814.318% |
| Wanbury Limited | 559.56 Million INR | -3318.555% |
| Windlas Biotech Limited | 581.87 Million INR | -3187.498% |
| ZIM Laboratories Limited | 172.46 Million INR | -10991.571% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 50.437% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 594.016% |
| Divi's Laboratories Limited | 16 Billion INR | -19.556% |
| Hester Biosciences Limited | 188.89 Million INR | -10027.041% |
| Procter & Gamble Health Limited | 2 Billion INR | -851.785% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -4153.471% |
| Bal Pharma Limited | 73.92 Million INR | -25777.231% |
| Strides Pharma Science Limited | -706.14 Million INR | 2808.948% |
| Venus Remedies Limited | 284.9 Million INR | -6614.086% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -781.918% |
| Nectar Lifesciences Limited | 49.95 Million INR | -38196.23% |
| Shilpa Medicare Limited | 318.74 Million INR | -5901.395% |
| Aarti Drugs Limited | 1.71 Billion INR | -1015.924% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -1322.969% |
| Suven Life Sciences Limited | -1.05 Billion INR | 1920.483% |
| Ind-Swift Limited | 142.31 Million INR | -13341.475% |
| Valiant Laboratories Limited | 3.19 Million INR | -598428.379% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -246.146% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 437.14% |
| Themis Medicare Limited | 435.23 Million INR | -4295.059% |
| Hikal Limited | 696.02 Million INR | -2648.336% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | -15.487% |
| Sequent Scientific Limited | -358.69 Million INR | 5433.008% |
| Novartis India Limited | 851.9 Million INR | -2145.447% |
| Wockhardt Limited | -4.63 Billion INR | 513.153% |
| Jubilant Pharmova Limited | 771 Million INR | -2381.059% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -269625.987% |
| Neuland Laboratories Limited | 3 Billion INR | -537.465% |
| Morepen Laboratories Limited | 961.59 Million INR | -1889.287% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -13000.776% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 21186.419% |